Related Experiment Videos
Liver transplantation for hepatocellular carcinoma
1Department of Surgery, University of Kentucky, Lexington, USA.
Hepato-Gastroenterology
|December 5, 1998
Summary
Liver transplantation (LT) for hepatocellular carcinoma (HCC) improves outcomes with careful patient selection. Selected HCC patients may achieve long-term survival comparable to other LT indications, potentially exceeding liver resection benefits.
Area of Science:
- Hepatology
- Surgical Oncology
- Transplant Surgery
Background:
- Liver transplantation (LT) for hepatocellular carcinoma (HCC) remains controversial.
- Past reports of poor outcomes may stem from advanced tumors and inadequate patient selection.
- Improved surgical techniques and selection criteria enhance LT results for HCC.
Purpose of the Study:
- To evaluate the efficacy and outcomes of LT in selected HCC patients.
- To determine if LT for HCC can yield results comparable to LT for other liver diseases.
- To assess the long-term survival benefit of LT versus liver resection in cirrhotic patients with HCC.
Main Methods:
- Review of patient selection criteria for LT in HCC.
- Analysis of preoperative tumor characteristics assessment.
- Comparison of outcomes between LT for HCC and LT for other indications.
- Comparative survival analysis of LT versus liver resection for HCC in cirrhotic patients.
Main Results:
- Careful patient selection and preoperative assessment are crucial for successful LT in HCC.
- Outcomes for carefully selected HCC patients undergoing LT can be similar to those for other LT indications.
- LT may offer superior long-term survival compared to liver resection for cirrhotic patients with HCC.
Conclusions:
- LT is a viable and effective treatment option for carefully selected HCC patients.
- Optimized patient selection significantly impacts LT success rates in HCC.
- LT provides a potential survival advantage over liver resection for eligible cirrhotic patients with HCC.